Literature DB >> 26442799

Gene Therapy for Heart Failure: Back to the Bench.

Seppo Ylä-Herttuala.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26442799      PMCID： PMC4817921          DOI： 10.1038/mt.2015.158

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  2 in total

1.  Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.

Authors:  Marcin Gruchała; Shalini Bhardwaj; Katri Pajusola; Himadri Roy; Tuomas T Rissanen; Ilze Kokina; Ivana Kholová; Johanna E Markkanen; Juha Rutanen; Tommi Heikura; Kari Alitalo; Hansruedi Büeler; Seppo Ylä-Herttuala
Journal:  J Gene Med       Date:  2004-05       Impact factor: 4.565

2.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Authors:  Mariell Jessup; Barry Greenberg; Donna Mancini; Thomas Cappola; Daniel F Pauly; Brian Jaski; Alex Yaroshinsky; Krisztina M Zsebo; Howard Dittrich; Roger J Hajjar
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690
  2 in total
  4 in total

Review 1.  Cardiovascular Gene Therapy: Past, Present, and Future.

Authors:  Seppo Ylä-Herttuala; Andrew H Baker
Journal:  Mol Ther       Date:  2017-04-04       Impact factor: 11.454

2.  Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.

Authors:  Edith Renaud-Gabardos; Florence Tatin; Fransky Hantelys; Benoît Lebas; Denis Calise; Oksana Kunduzova; Bernard Masri; Françoise Pujol; Pierre Sicard; Philippe Valet; Jérôme Roncalli; Xavier Chaufour; Barbara Garmy-Susini; Angelo Parini; Anne-Catherine Prats
Journal:  Mol Ther       Date:  2017-11-16       Impact factor: 11.454

Review 3.  Recent advances in gene therapy for atrial fibrillation.

Authors:  Shin Yoo; Gail Elizabeth Geist; Anna Pfenniger; Markus Rottmann; Rishi Arora
Journal:  J Cardiovasc Electrophysiol       Date:  2021-07-06       Impact factor: 2.942

Review 4.  Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.

Authors:  T Jake Samuel; Ryan P Rosenberry; Seungyong Lee; Zui Pan
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.